Variation in Anti-Mullerian Hormone Levels with Age in Women Accessing In Vitro Fertilization Services in Ghana
<strong>Background: </strong>The emergence of AMH as a reliable biomarker for assessing ovarian reserve and optimization of assisted reproductive technology (ART) remains a promising tool for the evaluation and prediction of controlled ovarian stimulation (COS) outcomes. This study asses...
Main Authors: | Dickson Mawusi, Kwame Adu-Bonsaffoh, Chrissie Stansie Abaidoo, Frederick Kwaku Addai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Reproductive Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-3897/3/3/20 |
Similar Items
-
Serum anti-Müllerian hormone (AMH) concentration during pregnancy: a longitudinal study
by: Sarah McCredie, et al.
Published: (2023-04-01) -
Clinical Utilities of Anti-Müllerian Hormone
by: Nicole Russell, et al.
Published: (2022-12-01) -
A role of anti-Mullerian hormone in external genital endometriosis
by: A. S. Molotkov, et al.
Published: (2021-05-01) -
Correlation of Anti-Müllerian Hormone with Polycystic Ovarian Disease and its Relation with Age
by: Sara Omer Muhammed, et al.
Published: (2019-08-01) -
Prediction of the lower serum anti-Müllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys® AMH assay: a prospective observational study
by: A. G. Grynnerup, et al.
Published: (2019-01-01)